Fabrice Hurbin
- Cardiology and Cardiovascular Medicine top 5%
- Surgery
- Pharmacology top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Pharmacology top 5%
- Co-authors
- Laurent PerrinFrank LaCretaL. BergougnanM. DubarCéline OllierShuk Han ChengDominick J. AngiolilloOlivier Nicolas
- Topics
- Antiplatelet Therapy and Cardiovascular Diseases (6 papers)Diabetes Treatment and Management (5 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Journals
- Journal of Allergy and Clinical ImmunologyClinical Pharmacology & TherapeuticsThrombosis and Haemostasis
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Fabrice Hurbin
18 papers receiving 545 citations
Peers
Comparison fields: 5 of 68
- Cardiology and Cardiovascular Medicine 354
- Surgery 137
- Pharmacology 133
- Endocrinology, Diabetes and Metabolism 123
- Pharmacology 104
Countries citing papers authored by Fabrice Hurbin
This map shows the geographic impact of Fabrice Hurbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Hurbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Hurbin more than expected).
Fields of papers citing papers by Fabrice Hurbin
This network shows the impact of papers produced by Fabrice Hurbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Hurbin. The network helps show where Fabrice Hurbin may publish in the future.
Co-authorship network of co-authors of Fabrice Hurbin
This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Hurbin. A scholar is included among the top collaborators of Fabrice Hurbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Hurbin. Fabrice Hurbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 22 | |
| 9 | 7 | |
| 10 | 24 | |
| 11 | 38 | |
| 12 | 34 | |
| 13 | 81 | |
| 14 | 69 | |
| 15 | 12 | |
| 16 | 214 | |
| 17 | 9 | |
| 18 | 15 |
About Fabrice Hurbin
Fabrice Hurbin is a scholar working on Family Practice, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 562 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Diabetes Treatment and Management (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (354 citations), Internal Medicine (52 citations) and Pharmacology (104 citations). Fabrice Hurbin has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Laurent Perrin, Frank LaCreta, L. Bergougnan, M. Dubar, Céline Ollier, Shuk Han Cheng, Dominick J. Angiolillo, Olivier Nicolas, C. Michael Gibson and Nassim Djebli. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Clinical Pharmacology & Therapeutics and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.